Search

everythinglearnresearchcommunity

for

Search:↓

Nafarelin may effectively treat excessive hair growth in women by reducing certain hormone levels.

Measuring androstanediol glucuronide in blood is useful for assessing and tracking treatment in women with excessive hair growth.

A 14-year-old girl with no menstrual period was diagnosed with Swyer Syndrome and treated for a related cancer risk.

Finasteride, when taken daily, lowers dihydrotestosterone levels but doesn't noticeably affect adrenal steroid production, except by blocking the 5 alpha-reductase enzyme.

Women with androgenic alopecia are more likely to have polycystic ovaries and higher androgen levels, which may indicate PCOS.

Myo-inositol helps improve skin conditions and metabolic profiles in young women with PCOS.

Melatonin and mitotane treatment led to hair re-growth in 62% of dogs with Alopecia X, but this was not always linked to normal hormone levels.

Flutamide combined with a low-dose birth control pill effectively reduces excessive hair growth in women with polycystic ovarian disease.

Metformin improved menstrual cycle regularity and signs of hyperandrogenism in adolescent girls with type 1 diabetes but did not improve blood sugar control.

3α, 17β-androstanediol-glucuronide is not a useful marker for androgen excess but may help monitor certain treatments.

Most women with polycystic ovary syndrome (PCOS) have menstrual issues, infertility, acne, and excessive body hair, with the most common type being the non-androgenic phenotype.

Hirsutism is more linked to high androgen levels than acne or hair loss, and a mix of hormonal tests is best for diagnosis; certain treatments can reduce symptoms.

Finasteride safely lowers DHT levels without affecting testosterone.

A new gene mutation causes female pseudohermaphroditism due to glucocorticoid resistance.

Men with male pattern hair loss have different levels of certain hormones compared to men without hair loss.

A patient with untreated congenital adrenal hyperplasia had large benign tumors in her adrenal glands removed, improving her symptoms.

Diagnosing hyperandrogenism in women is complex and requires accurate testing methods and consideration of SHBG levels.

The treatment significantly reduced hair growth and male hormone levels in hirsute women.

People with hair loss may have different levels of certain hormones due to changes in hormone processing.

Women with severe acne, hirsutism, and androgenic alopecia often have higher levels of certain androgens, but the specific pattern can't be predicted just by looking at symptoms.

Obesity changes androgen levels in women with PCOS, leading to higher testosterone relative to androstenedione.

Higher androstenedione levels in women with PCOS are linked to more severe symptoms.

Platelet-Rich Plasma (PRP) therapy can effectively treat various hair loss conditions, improve hair count, thickness, and density, and potentially speed up results when combined with surgical techniques.

Testosterone makes the connections in the uterus lining simpler and lowers certain protein levels, which might lead to infertility.

Androstenedione, a hormone supplement, doesn't improve muscle or performance and can cause harmful side effects.

Metformin and rosiglitazone both improved insulin use and hormonal symptoms in women with PCOS.

The new compounds moderately block a specific enzyme and strongly counteract a male hormone, suggesting potential for treating certain male-related health conditions.

New compounds were made that effectively block a specific enzyme related to androgen conditions.

Androstenedione is better than testosterone for diagnosing PCOS in Indian women.

Using two drugs together, Flutamide and 4-MA, is more effective for blocking male hormones than using each one alone.